Dynamics of the Opioid Receptor Signaling Complex

阿片受体信号复合物的动力学

基本信息

  • 批准号:
    9095376
  • 负责人:
  • 金额:
    $ 38.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Funds are requested to carry out NMR studies to develop a deeper understanding of the dynamic behavior of G-Protein Coupled Receptors (GPCRs) and their signaling complexes to enable the construction of a better model of their mechanism of action. GPCRs are critical eukaryotic signal transduction gatekeepers which recognize a variety of extracellular stimuli, including photons, ions, small molecules, peptides and proteins. They transmit the resulting extracellular signal across the membrane by coupling to different intracellular proteins which then activate downstream effectors and trigger cascades of cellular and physiological responses. This has profound therapeutic implications, making these receptors the targets of ~30% of currently prescribed drugs. Developing a better understanding of how they work is, therefore, expected to help in developing new and better drugs targeting them. Although there has been a dramatic growth in the number of structures of GPCRs bound to antagonists, agonists including biased ligands, inverse agonists, and allosteric modulators, the molecular mechanisms of activation remain poorly understood. The proposed study rests on the premise that needed clarity can be achieved with a better understanding of the dynamic behavior of the system. We plan to characterize the dynamic behavior of all the members of the opioid family of receptors (Class A, -subfamily). There are four members in this family - the classical opioid receptors (OR) -, -, , (MOR, KOR, DOR) and the nociceptn receptor (NOP), all of which are coupled predominantly to heterotrimeric Gi/Go proteins. ORs are acted on by opioids which have had a long history in both chronic and acute pain control and addiction. This funding request is to support studies on KOR and the development of new knowledge and protocols that could be applied to the rest of the family. We will achieve a better understanding of the mechanism of action including the activation process through three specific aims: (1) Develop an understanding of the dynamic conformational landscape of KOR in the active and inactive state, (2) Develop an understanding of the dynamic behavior of the KOR signaling complex, and (3) Develop an understanding of the KOR-dynorphin interaction in the "low" and "high" affinity states. In this proposal, we will use our newly developed 19F NMR approach to characterize the dynamic behavior of KOR and standard NMR techniques for 2H/13C/15N NMR studies of the peptide dynorphin and the signaling partners to characterize changes to their dynamic behavior on binding to KOR. Studies will allow us to explore various questions, answers to which will help us build a better model describing the activation process. In addition, protocols and reagents generated in the study should help establish a new platform for developing new drugs targeting opioid receptors with reduced or minimal side-effects.
 描述(由申请人提供):要求提供资金进行NMR研究,以更深入地了解G蛋白偶联受体(GPCR)及其信号复合物的动态行为,从而能够构建更好的作用机制模型。GPCR是真核生物信号转导的重要看门人,它识别各种细胞外刺激,包括光子、离子、小分子、肽和蛋白质。它们通过偶联到不同的细胞内蛋白质,然后激活下游效应器并触发细胞和生理反应的级联反应,从而跨膜传递所得的细胞外信号。这具有深远的治疗意义,使这些受体成为目前约30%处方药物的靶点。因此,更好地了解它们是如何工作的,预计将有助于开发针对它们的新的和更好的药物。尽管与拮抗剂、激动剂(包括偏向性配体、反向激动剂和变构调节剂)结合的GPCR的结构数量急剧增长,但激活的分子机制仍然知之甚少。所提出的研究基于这样的前提,即通过更好地理解系统的动态行为可以实现所需的清晰度。我们计划描述阿片受体家族(A类,β-亚家族)所有成员的动态行为。该家族中有四个成员-经典阿片受体(OR)β-、(莫尔、KOR、DOR)和伤害感受素受体(NOP),所有这些受体主要与异源三聚体Gi/Go蛋白偶联。阿片类药物对OR起作用,阿片类药物在慢性和急性疼痛控制和成瘾方面都有悠久的历史。这项资金申请是为了支持对KOR的研究,以及开发可适用于该家族其他成员的新知识和协议。我们将通过三个具体目标更好地理解包括激活过程在内的作用机制:(1)了解KOR在活性和非活性状态下的动态构象景观,(2)了解KOR信号复合物的动态行为,(3)了解KOR-dynorphin在“低”和“高”亲和力状态下的相互作用。在这项提案中,我们将使用我们新开发的19 F NMR方法来表征KOR的动态行为,并使用标准NMR技术对肽强啡肽和信号伴侣进行2 H/13 C/15 N NMR研究,以表征其与KOR结合时动态行为的变化。研究将使我们能够探索各种问题,这些问题的答案将帮助我们建立一个更好的模型来描述激活过程。此外,研究中产生的方案和试剂应该有助于建立一个新的平台,用于开发靶向阿片受体的新药,减少或减少副作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kurt Wuthrich其他文献

Kurt Wuthrich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kurt Wuthrich', 18)}}的其他基金

Dynamics of the Opioid Receptor Signaling Complex
阿片受体信号复合物的动力学
  • 批准号:
    8944883
  • 财政年份:
    2015
  • 资助金额:
    $ 38.02万
  • 项目类别:
NMR Core
核磁共振核心
  • 批准号:
    8151687
  • 财政年份:
    2010
  • 资助金额:
    $ 38.02万
  • 项目类别:
NMR Core
核磁共振核心
  • 批准号:
    8376404
  • 财政年份:
  • 资助金额:
    $ 38.02万
  • 项目类别:
NMR Core
核磁共振核心
  • 批准号:
    8511711
  • 财政年份:
  • 资助金额:
    $ 38.02万
  • 项目类别:
NMR Core
核磁共振核心
  • 批准号:
    8692873
  • 财政年份:
  • 资助金额:
    $ 38.02万
  • 项目类别:
NMR Core
核磁共振核心
  • 批准号:
    8290375
  • 财政年份:
  • 资助金额:
    $ 38.02万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了